These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32196825)

  • 1. Factors shaping at-risk individuals' decisions to undergo genetic testing for cancer in Asia.
    Sun S; Li ST; Ngeow J
    Health Soc Care Community; 2020 Sep; 28(5):1569-1577. PubMed ID: 32196825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.
    Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D
    Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living with genetic test results for hereditary breast and ovarian cancer.
    Hamilton R; Williams JK; Skirton H; Bowers BJ
    J Nurs Scholarsh; 2009; 41(3):276-83. PubMed ID: 19723276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
    Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
    Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.
    Dean M; Rauscher EA
    J Genet Couns; 2017 Dec; 26(6):1301-1313. PubMed ID: 28138923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.
    Phelps C; Wood F; Bennett P; Brain K; Gray J
    J Genet Couns; 2007 Aug; 16(4):505-14. PubMed ID: 17318449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
    Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH
    Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the decision to share cancer genetic results among family members: An in-depth interview study of women in an Asian setting.
    Li ST; Sun S; Lie D; Met-Domestici M; Courtney E; Menon S; Lim GH; Ngeow J
    Psychooncology; 2018 Mar; 27(3):998-1004. PubMed ID: 29314485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
    Sherman KA; Kasparian NA; Mireskandari S
    Psychooncology; 2010 Jan; 19(1):1-11. PubMed ID: 19472298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
    Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
    Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global celebrities' effect on health awareness among Jordanians: A study using the case of Angelina Jolie.
    Al-Hussaini M; Ammar K; Kasasbeh N; Sultan H; Al-Omari A
    J Genet Couns; 2019 Oct; 28(5):1021-1028. PubMed ID: 31386265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing for hereditary breast and ovarian cancer: responsibility and choice.
    d'Agincourt-Canning L
    Qual Health Res; 2006 Jan; 16(1):97-118. PubMed ID: 16317179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
    Nippert I; Schlegelberger B;
    Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
    Phillips KA; Warner E; Meschino WS; Hunter J; Abdolell M; Glendon G; Andrulis IL; Goodwin PJ
    Clin Genet; 2000 May; 57(5):376-83. PubMed ID: 10852372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
    Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
    Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer.
    Andersen MR; Bowen D; Yasui Y; McTiernan A
    Am J Obstet Gynecol; 2003 Oct; 189(4 Suppl):S42-7. PubMed ID: 14586320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.